Increase your pipeline’s success rates and improve scalability by generating and activating biotech insights that support both early-stage and established companies.
Drawing from our comprehensive knowledge of the biotech landscape, and specialized expertise in rare disease markets, we equip our clients with tailored strategies to accelerate product development and optimize market access.
Access insights and approaches designed to best navigate the unique challenges of biotech and rare disease initiatives across our main areas of expertise.
KJT is more than just a vendor, they’re a partner. They always offer a tailored approach and are very responsive.
KJT helped figure out where we have been successful in influencing the market and pinpointed areas to focus on. We will be using suggestions that were provided.
In pharmaceutical market research, one element remains consistently crucial: participant…
Publishing real-world evidence (RWE) research involves a comprehensive journey of strategic…
Understanding what goes on in the exam room between patients and HCPs remains a critical yet…
Real-world evidence (RWE) is only as meaningful as the perspectives it includes. While healthcare…
Synthetic data is not new to market research, and the healthcare insights industry is starting to…
Digital twins are reshaping the way we generate insights across industries. In this webinar, we…
Having spent 25 years in the consumer research sector (finance, CPG, retail, tech, etc), I am used…
I have attended more than half of the PMRC conferences held over the past 16 years. Being a veteran…
Rare disease patients face unique challenges that are often overlooked or misunderstood by those…
AI is transforming the way we collect and analyze qualitative data—but rather than replacing…
